An allogeneic bone marrow transplant (BMT) is a specialized treatment in which healthy blood-forming stem cells are collected from a suitable donor and infused into the patient. The new stem cells can help restore healthy blood-cell production after intensive treatment for certain blood cancers and bone marrow disorders.
Who May Need an Allogeneic BMT?
Doctors may consider an allogeneic stem cell transplant for conditions such as acute leukemia, myelodysplastic syndromes, lymphoma, aplastic anemia, and selected inherited or immune-related blood disorders. Suitability depends on the diagnosis, disease status, overall health, previous treatments, and availability of a compatible donor.
How Is the Treatment Performed?
Before transplantation, the patient may receive chemotherapy, with or without radiation, as conditioning therapy. Donor stem cells are then infused through a vein. Over the following weeks, the transplanted cells begin establishing themselves in the bone marrow and producing new blood cells.
Donor Matching and Preparation
HLA matching is an important part of donor selection. A close match may be found among siblings, relatives, or through an unrelated donor registry. The transplant team evaluates both donor and recipient carefully before proceeding.
Recovery and Follow-Up
Recovery after allogeneic bone marrow transplantation requires close medical monitoring. Patients may need regular blood tests, infection prevention, medicines, nutritional support, and follow-up appointments. Doctors also monitor for complications such as graft-versus-host disease (GVHD) and other transplant-related effects.